Rgs10 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
RGS10
| Symbol | RGS10 |
| Full Name | Regulator of G Protein Signaling 10 |
| Chromosome | 10q26.11 |
| NCBI Gene ID | 6004 |
| OMIM | 602866 |
| Ensembl ID | ENSG00000148991 |
| UniProt ID | Q9NS28 |
| Encoded Protein | RGS10 Protein |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis |
The RGS10 gene encodes RGS10 Protein, a Regulator of G-protein signaling (RGS) protein that plays critical roles in GTPase-activating protein modulating G-protein mediated signaling. This gene is implicated in the pathogenesis of several neurodegenerative diseases through its involvement in neuroinflammation, dopaminergic signaling, cell survival.
RGS10 encodes a member of the regulator of G protein signaling (RGS) family that acts as a GTPase-activating protein (GAP) for heterotrimeric G proteins, particularly Gαi and Gαo subunits. RGS10 is unique among RGS proteins for its small size and nuclear localization. It plays important roles in modulating neuroinflammation by regulating G protein-coupled receptor (GPCR) signaling in microglia and astrocytes. RGS10 also regulates dopaminergic signaling and has been implicated in neuronal survival pathways. Its expression is modulated in several neurodegenerative diseases, and it may serve as a therapeutic target for neuroinflammatory conditions.
| Disease | Inheritance | Key Mutations |
|---|---|---|
| Alzheimer's Disease | Various | Pathogenic variants |
| Parkinson's Disease | Various | Pathogenic variants |
| Multiple Sclerosis | Various | Pathogenic variants |
In Alzheimer's disease, RGS10 expression is altered in brain regions affected by amyloid-beta pathology. RGS10 modulates microglial activation and neuroinflammatory responses through GPCR signaling. In Parkinson's disease, RGS10 regulates dopaminergic neuron survival through modulation of Gαi/o signaling. Altered RGS10 expression has been observed in multiple sclerosis lesions, suggesting a role in demyelination and neuroinflammation.
RGS10 is widely expressed in the brain, with high expression in the cerebral cortex, hippocampus, basal ganglia, and cerebellum. It is also expressed in immune cells including microglia and astrocytes, where it regulates inflammatory responses.
The study of Rgs10 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.